Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
9-valent pneumococcal conjugate vaccine efficacy trial in Gambian infants
ISRCTN46147225Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2000
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, double-blind trial in pneumococcal disease, Pneumococcal pneumonia (PP) and invasive pneumococcal disease (IPD) comparing Nine-valent pneumococcal conjugate vaccine with Placebo (2 arms). Primary endpoint: First episode of radiological pneumonia. Started Aug 2000; status: completed.
02
Drugs
nine-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal diseasePneumococcal pneumonia (PP)invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on ISRCTN46147225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN46147225.